Monogram Technologies Inc. (MGRM) - Cumulative Company Assets

Public company logo of Monogram Technologies Inc. (MGRM)

Monogram Technologies (MGRM) is currently in the innovation go-to-market phase, where primary growth depends on regulatory approvals and initial contracts. The company generates revenue through the creation of customized 3D implants and robotic systems for orthopedics. This stock price chart shows that total assets amount to 12.78, although development is complicated by a reliance on Asian microchips and trade war risks.

Monogram Technologies Inc. (MGRM) Company Total Assets: for the period 02/21/2024 - 10/18/2025

Comprehensive metric breakdowns and analytics for Monogram Technologies Inc (MGRM)

- price and consensus price forecast:
Stock Quotes monogramorthopedics.com|MGRM - Price Target Chart
- market capitalization data:
Market Valuation Monogram Orthopedics Inc.|MGRM - Enterprise Value
- book capitalization data:
Net Asset Value per Share Monogram Orthopedics|MGRM - Book Capitalization|Capitalization to Book Value Ratio monogramorthopedics.com|MGRM - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Monogram Technologies|MGRM - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Monogram Orthopedics Inc.|MGRM - Company Aggregate Debts|Debts to Book Capitalization Monogram Orthopedics Inc.
Fundamental valuation:monogramorthopedics.com, MGRM
Manufactured product of Monogram Technologies

Total assets represent the aggregate value of the company's resources, calculated inversely via return on assets (ROA) to capture capital micro-dynamics. By analyzing the total assets chart on the GURU.Markets platform, an investor assesses the efficiency of capital accumulation and the balance between expansion and risk. Growth in this metric confirms the scaling of the material base. For Monogram Technologies (MGRM), this reflects investments in the development of robotic systems and software for precision surgery.

Main competitors

ISRG (intuitive.com) - Cumulative Company Assets|Aggregate Company Assets DHR|Cumulative Company Assets BD|STERIS Corporation - Company Total Assets|Company Assets West Pharma Corp (WST)|BAX - Company Total Assets|Total Business Assets masimo.com MASI|Company Total Assets STVN (Stevanato Group)|TFX - Company Total Asset Base|MMSI (Merit Medical Systems Inc) - Company Total Assets|Nobel Biocare (NVST) - Cumulative Company Assets|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets XRAY|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets AtriCure Inc ATRC|Cumulative Company Assets STAAR Surgical Corp|Aggregate Asset Value ChromaDex NAGE|Company Total Assets ZIMV (ZimVie Inc.)|ANGO: Company Total Asset Base|Aggregate Company Assets Cerus|TKNO (Alpha Teknova) - Total Business Assets|STSS: Aggregate Company Assets|Company Total Asset Base InfuSystem Inc (INFU)|Cumulative Company Assets Utah Medical Products|Aggregate Business Assets KRMD (korumedical.com)|Aggregate Company Assets Nyxoah|MBOT - Aggregate Asset Value|Pro-Dex Corp - Cumulative Company Assets|ZTEK: Company Total Assets|ELUT (Elutia Inc.) - Aggregate Company Assets|milestonescientific.com (MLSS) - Cumulative Company Assets|Company Total Assets NXGL (NEXGEL)|Company Assets RVP|Aggregate Company Assets Harvard Bioscience HBIO|Total Business Assets Femasys Corporation FEMY|Cumulative Company Assets Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Aggregate Business Assets|Aggregate Company Assets CJMB (Callan JMB Corp)|ATRI: Company Total Asset Base|NURO (NeuroMetrix Corp) - Aggregate Company Assets